Get answers to your personal questions about HIV testing and learn more about the benefits of knowing your HIV status.
An estimated 1.2 million people in the United States have HIV, including about 158,500 people who are unaware of their status. Nearly 40% of new HIV infections are transmitted by people who don’t know they have the virus. For people with undiagnosed HIV, testing is the first step in maintaining a healthy life and preventing HIV transmission.
CDC’s Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings advises routine HIV screening of adults, adolescents, and pregnant women in health care settings in the United States. The recommendations also call for reducing barriers to HIV testing.
CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care. For people with certain risk factors, CDC recommends getting tested at least once a year.
Data from a clinical trial sponsored by the National Institutes of Health show clear benefits to being diagnosed with HIV early and starting treatment right away. This information also highlights the importance of routine HIV testing and its potential impact on better health outcomes.
Importance of HIV Testing for Prevention of HIV Infection
People with HIV who know their status can get HIV treatment (called antiretroviral therapy or ART) and remain healthy for many years. Studies show that the sooner people start HIV treatment after diagnosis, the more they benefit. HIV treatment reduces the amount of HIV in the blood (called viral load), reduces HIV-related illness, and prevents transmission to others. People with HIV who take HIV treatment as prescribed and get and keep an undetectable viral load (or stay virally suppressed) will not transmit HIV to their sex partners.
People who get tested and learn they don’t have HIV can make decisions about sex, drug use, and health care that can help prevent prevent HIV. Taking HIV medicine called pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV.
HIV Tests for Screening and Diagnosis
HIV tests are very accurate, but no test can detect the virus immediately after infection. How soon a test can detect HIV depends on the type of test being used. There are three types of HIV tests: antibody tests, antigen/antibody tests, and nucleic acid tests (NAT).
- Antibody tests look for antibodies to HIV in a person’s blood or oral fluid. Antibody testscan take 23 to 90 days to detect HIV after exposure. Most rapid tests and the only FDA-approved HIV self-test are antibody tests. In general, antibody tests that use blood from a vein can detect HIV sooner after infection than tests done with blood from a finger stick or with oral fluid.
- Antigen/antibody tests look for both HIV antibodies and antigens. Antibodies are produced by a person’s immune system when they’re exposed to viruses like HIV. Antigens are foreign substances that cause a person’s immune system to activate. If a person has HIV, an antigen called p24 is produced before antibodies develop. Antigen/antibody tests are recommended for testing done in labs and are common in the United States. An antigen/antibody test performed by a lab on blood from a vein can usually detect HIV 18 to 45 days after exposure. There is also a rapid antigen/antibody test available that is done with a finger stick. Antigen/antibody tests done with blood from a finger stick can take 18 to 90 days after exposure.
- NATs look for the actual virus in the blood. This test should be considered for people who have had a recent exposure or a possible exposure with early symptoms of HIV and have tested negative with an antibody or antigen/antibody test. A NAT can usually detect HIV 10 to 33 days after exposure.
An initial HIV test usually will either be an antigen/antibody test or an antibody test. If the initial HIV test is a rapid or self-test and it is positive, the person should go to a health care provider to get follow-up testing. If the initial HIV test is a lab test and it is positive, the lab will usually conduct follow-up testing on the same blood sample as the initial test. Although HIV tests are generally accurate, follow-up tests allow the health care provider to confirm the result.
Resources for FDA-approved lab tests, self-tests, and testing of self-collected samples are available. Learn more about HIV testing in nonclinical settings and HIV screening in clinical settings.
- CDC. Estimated HIV incidence and prevalence in the United States, 2015-2019. HIV Surveillance Supplemental Report 2021; 26(1).
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2020. HIV Surveillance Report 2022;33.
- CDC. Monitoring selected HIV prevention and care objectives by using HIV surveillance data, United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report 2020;27(3).
- CDC. HIV transmission along the continuum of care—United States,2016. MMWR 2019;68(11);267-72.
- CDC. Interval since last HIV test for men and women with recent risk for HIV infection—United States, 2006-2016. MMWR 2018;67(24);677-81.
- CDC. HIV infection, risk, prevention, and testing behaviors among persons who inject drugs—national HIV behavioral surveillance: injection drug use, 23 U.S. cities, 2018. HIV Surveillance Special Report 2020;24.
- CDC. HIV infection, risk, prevention, and testing behaviors among men who have sex with men—national HIV behavioral surveillance, 23 U.S. cities, 2017. HIV Surveillance Special Report 2019;22.
- CDC. HIV infection, risk, prevention, and testing behaviors among heterosexually active adults at increased risk for HIV infection—national HIV behavioral surveillance, 23 U.S. cities, 2019. HIV Surveillance Special Report 2021;26.
- CDC. Human immunodeficiency virus testing and diagnosis delays—United States, 2017. MMWR 2017; 66(47);1300-6.
- CDC. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men—United States, 2017. MMWR 2017;66(31);830-2.
- CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55:1-17.
- CDC and Association of Public Health Laboratories. Laboratory testing for the diagnoses of HIV infection: updated recommendations. Accessed May 11, 2022.
- Delaney KP, Hanson DL, Masciotra S, Ethridge SF, Wesolowski L, Owen SM. Time until emergence of HIV test reactivity following infection with HIV-1: Implications for interpreting test results and retesting after exposure. Clin Infect Dis 2017;64(1):53-9. PubMed abstract.
- Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med 2015;175:588-96. PubMed abstract.